Company Vivos Therapeutics, Inc.

Equities

VVOS

US92859E2072

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change
2.125 USD -2.97% Intraday chart for Vivos Therapeutics, Inc. -19.20% -82.92%

Business Summary

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.

Number of employees: 119

Sales per Business

USD in Million2022Weight2023Weight Delta
Oral Appliances and Therapeutic Treatments
100.0 %
16 100.0 % 14 100.0 % -13.87%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
16 100.0 % 14 100.0 % -13.87%

Managers

Managers TitleAgeSince
Founder - 16-07-06
Founder - 16-07-06
Founder - 16-07-06
Chief Executive Officer 66 16-07-06
Director of Finance/CFO 62 18-09-30
Chief Tech/Sci/R&D Officer 51 -
Investor Relations Contact - -
Sales & Marketing - -
- -
Corporate Officer/Principal - 19-09-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 20-05-31
Director/Board Member 61 20-05-31
Director/Board Member 56 20-05-31
Director/Board Member 84 20-05-31
Chief Executive Officer 66 16-07-06
Director/Board Member 62 20-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,982,270 2,780,421 ( 93.23 %) 0 93.23 %

Shareholders

NameEquities%Valuation
Armistice Capital LLC
6.411 %
175,099 6.411 % 845 728 $
Strategic Wealth Designers LLC
4.715 %
128,789 4.715 % 622 051 $
128,788 4.715 % 622 046 $
73,061 2.675 % 352 885 $
Armistice Capital LLC
2.087 %
57,000 2.087 % 275 310 $
Schonfeld Strategic Advisors LLC
1.834 %
50,100 1.834 % 241 983 $
Commonwealth Equity Services LLC
0.5492 %
15,000 0.5492 % 72 450 $
Vanguard Group, Inc. (Subfiler)
0.3873 %
10,579 0.3873 % 51 097 $
CA Indosuez (Switzerland) SA
0.0866 %
2,365 0.0866 % 11 423 $
Newbridge Financial Services Group, Inc.
0.0714 %
1,950 0.0714 % 9 419 $

Company contact information

Vivos Therapeutics, Inc.

7921 Southpark Plaza Suite 210

80120, Littleton

+

http://www.vivoslife.com
address Vivos Therapeutics, Inc.(VVOS)
  1. Stock Market
  2. Equities
  3. VVOS Stock
  4. Company Vivos Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW